At SWN, we believe the future of healthcare innovation in Indonesia will be shaped not only by capital, but by collaboration across the entire ecosystem.
Yesterday, we had the opportunity to support and moderate a session hosted by LLV, the corporate venture capital arm of Sinar Mas Land, on Investing in Healthcare: Navigating the Future of Healthcare Innovation in Indonesia.
Together with Alfons Wijaya (VP Investment & Portfolio Management, LLV), the discussion explored a fundamental question: What will it take to truly transform healthcare in Indonesia?
Some key insights from the session:
• Healthcare demand in Indonesia is structural, not cyclical
Indonesia accounts for nearly 40% of ASEAN’s healthcare spending, yet healthcare allocation remains at only 3–4% of GDP, highlighting a long-term opportunity driven by unmet demand.
• Healthcare investing requires a long-term perspective
Success in this sector depends on balancing clinical validity, regulatory readiness, and sustainable relevance. Many transformative innovations initially appear “too early” before becoming essential.
• Scaling healthcare goes beyond replication
As healthcare businesses grow, maintaining quality, trust, and consistency becomes critical. Longitudinal patient data will increasingly become a strategic differentiator.
• Why Indonesia, why now?
With a population of 285M+, growing middle-class expectations, and significant outbound medical travel, Indonesia presents strong demand for improved healthcare access and innovation.
• Capital is increasingly flowing into technology-enabled healthcare
Areas such as diagnostics, biomedical innovation, AI-driven drug discovery, early cancer detection, and preventive care continue to gain momentum as the industry shifts toward predictive healthcare models.
• Collaboration remains the key enabler
Healthcare transformation cannot be driven by investors alone. Progress will require alignment between government, private sector, healthcare providers, and global partners.
Thank you to LLV, Alfons Wijaya, and everyone who joined the session and contributed to the discussion on the future of healthcare innovation in Indonesia.
